J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg

Nov 24 (Reuters) - U.S. healthcare company Johnson & Johnson

has approached Swiss biotechnology firm Actelion Ltd

about a potential takeover, Bloomberg reported on

Thursday, citing people it said were familiar with the matter.

Read more